Table 2. Post NACI CT evaluation.
| Parameters | pre-NACI CT, N=19 (%) | post-NACI CT, N=19 (%) |
|---|---|---|
| Tumor | ||
| T2 | 0 (0) | 3 (15.79) |
| T3 | 18 (94.97) | 15 (78.91) |
| T4a | 1 (5.26) | 1 (5.26) |
| Lymph node | ||
| N1 | 13 (68.42) | 16 (84.21) |
| N2 | 5 (26.32) | 2 (10.53) |
| N3 | 1 (5.26) | 1 (5.26) |
| cTNM stage | ||
| III | 13 (68.42) | 16 (84.21) |
| IVA | 6 (31.58) | 3 (15.79) |
| Response rate | ||
| PR | 13 (68.42) | |
| SD | 6 (31.58) |
NACI, neoadjuvant chemotherapy combined with immunotherapy.